pharmaceutical research

Late-Stage Melanoma Sufferers Have More Treatment Options
Thanks To Drug Approval

Late-Stage Melanoma Sufferers Have More Treatment Options Thanks To Drug Approval

The Food and Drug Administration is bringing in reinforcements for those who suffer inoperable forms of melanoma. Zelboraf, which was recently approved by the government, joins Yervoy — approved in March — as new drugs that doctors believe will help patients live longer after treatment. [More]